Tobira Development Company Profile (NASDAQ:TBRA)

About Tobira Development (NASDAQ:TBRA)

Tobira Development logoTobira Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapies for non-alcoholic steatohepatitis (NASH) and other liver diseases. The Company's product candidate, cenicriviroc (CVC), is a first-in-class immunomodulator and dual inhibitor of C-C chemokine receptor type 2 (CCR2) and C-C chemokine receptor type 5 (CCR5) in late stage development for the treatment of NASH, a serious liver disease that can progress to cirrhosis, liver cancer and liver failure. CVC is also being investigated to address primary sclerosing cholangitis (PSC), a disease which causes inflammation and scarring of the bile ducts, eventually leading to liver damage. The Company's pipeline also includes evogliptin, a selective dipeptidyl peptidase 4 (DPP-4) inhibitor, which it plans to develop for NASH in combination with CVC.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: $35.35
  • 200 Day Moving Avg: $15.25
  • 52 Week Range: $3.76 - $42.33
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -19.31
  • P/E Growth: 0.00
Profitability:
  • Return on Assets: -153.93%
Debt:
  • Debt-to-Equity Ratio: 0.44%
  • Current Ratio: 5.38%
  • Quick Ratio: 5.38%
Misc:
  • Average Volume: 583,983 shs.
  • Beta: -2.38
 

Frequently Asked Questions for Tobira Development (NASDAQ:TBRA)

What is Tobira Development's stock symbol?

Tobira Development trades on the NASDAQ under the ticker symbol "TBRA."

How were Tobira Development's earnings last quarter?

Tobira Development Inc (NASDAQ:TBRA) announced its quarterly earnings results on Tuesday, August, 9th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.63) by $0.08. The firm had revenue of $1.06 million for the quarter, compared to the consensus estimate of $0.15 million. View Tobira Development's Earnings History.

Where is Tobira Development's stock going? Where will Tobira Development's stock price be in 2017?

0 equities research analysts have issued 12 month target prices for Tobira Development's shares. Their forecasts range from $10,000,000.00 to $0.00. On average, they anticipate Tobira Development's stock price to reach $0.00 in the next year. View Analyst Ratings for Tobira Development.

Who are some of Tobira Development's key competitors?

How do I buy Tobira Development stock?

Shares of Tobira Development can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tobira Development's stock price today?

One share of Tobira Development stock can currently be purchased for approximately $42.09.


MarketBeat Community Rating for Tobira Development (NASDAQ TBRA)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  120 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  182
MarketBeat's community ratings are surveys of what our community members think about Tobira Development and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Tobira Development (NASDAQ:TBRA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Tobira Development (NASDAQ:TBRA)
Price Target History for Tobira Development (NASDAQ:TBRA)
Analysts' Ratings History for Tobira Development (NASDAQ:TBRA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/22/2016Leerink SwannReiterated RatingOutperform$15.00 -> $45.00N/AView Rating Details
9/22/2016MizuhoReiterated RatingBuy$305.00N/AView Rating Details
9/21/2016Cantor FitzgeraldDowngradeBuy -> Hold$19.00 -> $42.00N/AView Rating Details
8/13/2016HC WainwrightReiterated RatingBuy$22.00 -> $31.00N/AView Rating Details
8/10/2016Cowen and CompanyReiterated RatingBuy$11.00N/AView Rating Details
(Data available from 10/23/2015 forward)

Earnings

Earnings History for Tobira Development (NASDAQ:TBRA)
Earnings by Quarter for Tobira Development (NASDAQ:TBRA)
Earnings History by Quarter for Tobira Development (NASDAQ TBRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016Q216($0.63)($0.71)$0.15 million$1.06 millionViewN/AView Earnings Details
5/9/2016Q116($0.53)($0.65)$0.11 millionViewN/AView Earnings Details
3/3/2016Q415($0.52)($0.50)ViewN/AView Earnings Details
11/10/2015Q315($1.00)($1.22)ViewListenView Earnings Details
8/11/2015Q215($0.99)ViewListenView Earnings Details
11/6/2014Q314($0.45)($0.59)ViewN/AView Earnings Details
8/11/2014Q214($0.51)($0.63)ViewN/AView Earnings Details
5/14/2014Q114($0.62)($1.30)ViewN/AView Earnings Details
11/7/2013($0.43)($1.43)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tobira Development (NASDAQ:TBRA)
Current Year EPS Consensus Estimate: $-2.60 EPS
Next Year EPS Consensus Estimate: $-2.18 EPS

Dividends

Dividend History for Tobira Development (NASDAQ:TBRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tobira Development (NASDAQ:TBRA)
Insider Ownership Percentage: 6.20%
Institutional Ownership Percentage: 62.42%
Insider Trades by Quarter for Tobira Development (NASDAQ:TBRA)
Institutional Ownership by Quarter for Tobira Development (NASDAQ:TBRA)
Insider Trades by Quarter for Tobira Development (NASDAQ:TBRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/31/2016Pentwater Capital Management LMajor ShareholderBuy15,000$41.84$627,600.00View SEC Filing  
10/18/2016Pentwater Capital Management LMajor ShareholderBuy40,000$40.06$1,602,400.00View SEC Filing  
10/17/2016Pentwater Capital Management LMajor ShareholderBuy31,700$40.07$1,270,219.00View SEC Filing  
10/4/2016Pentwater Capital Management LMajor ShareholderBuy4,481$39.83$178,478.23View SEC Filing  
9/29/2016Pentwater Capital Management LMajor ShareholderBuy15,519$39.49$612,845.31View SEC Filing  
9/26/2016Pentwater Capital Management LMajor ShareholderBuy50,000$39.00$1,950,000.00View SEC Filing  
9/23/2016Pentwater Capital Management LMajor ShareholderBuy100,000$39.19$3,919,000.00View SEC Filing  
9/22/2016Pentwater Capital Management LMajor ShareholderBuy1,624,200$39.04$63,408,768.00View SEC Filing  
7/13/2016A/S NovoMajor ShareholderSell59,067$12.02$709,985.34View SEC Filing  
7/7/2016A/S NovoMajor ShareholderSell92,119$12.20$1,123,851.80View SEC Filing  
6/30/2016A/S NovoMajor ShareholderSell66,814$13.04$871,254.56View SEC Filing  
6/6/2016A/S NovoMajor ShareholderSell187,500$10.37$1,944,375.00View SEC Filing  
3/4/2016A/S NovoMajor ShareholderSell190,000$6.80$1,292,000.00View SEC Filing  
11/18/2015A/S Novomajor shareholderSell225,000$9.79$2,202,750.00View SEC Filing  
5/4/2015A/S NovoMajor ShareholderBuy838,041$10.62$8,899,995.42View SEC Filing  
5/4/2015Parters Vii L P DomainMajor ShareholderBuy277,777$10.62$2,949,991.74View SEC Filing  
4/16/2014Robert Kierlinmajor shareholderBuy575,000$6.00$3,450,000.00View SEC Filing  
2/5/2014Robert Kierlinmajor shareholderBuy400,000$5.00$2,000,000.00View SEC Filing  
8/27/2013Raphael WisniewskiDirectorBuy1,215,708$4.00$4,862,832.00View SEC Filing  
8/27/2013Rmi Investments S.A.R.L.Major ShareholderBuy3,866,529$4.00$15,466,116.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Tobira Development (NASDAQ:TBRA)
Latest Headlines for Tobira Development (NASDAQ:TBRA)
Source:
Loading headlines, please wait.

Social

Chart

Tobira Development (TBRA) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.